- Update: FDA revises final guidances on interim policy for certain bulk drug substances used in compounding
- Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act
Guidance for Industry (PDF - 134KB) - Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance for Industry (PDF - 112KB)
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, January 17, 2017
Essential Reads for all involved in compounded drugs--
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment